Kisqali on PBS, very few will get it.
those of us who were waiting to get Ibrance or Kisqali on PBS we will not get either. Only newly the diagnosed who have NOT had an Aromatose drug. ( there would be very few of them ) BCNA failed t...
Forum Discussion
Hello @Wildplaces
Thanks for pointing this out. The post you highlight from Lisa was correct at the time of posting and was based on the application that Novartis submitted for Ribociclib and that BCNA endorsed.
However, when Ribociclib was listed on the PBS on 1st July, the listing was different and the only group excluded are premenopausal women.
Therefore, men are able to access Ribociclib through the PBS. We have contacted a number of men privately to make sure that they are aware of this. It is important however, that men talk to their medical oncologist regarding the suitability of this treatment for them as earlier clinical trials did not include men.
Thanks for pointing this out. The post you highlight from Lisa was correct at the time of posting and was based on the application that Novartis submitted for Ribociclib and that BCNA endorsed.
However, when Ribociclib was listed on the PBS on 1st July, the listing was different and the only group excluded are premenopausal women.
Therefore, men are able to access Ribociclib through the PBS. We have contacted a number of men privately to make sure that they are aware of this. It is important however, that men talk to their medical oncologist regarding the suitability of this treatment for them as earlier clinical trials did not include men.